Trintellix is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Vortioxetine Hydrobromide.
Product ID | 55154-0256_0cc35239-79cc-4787-8b43-673e10e3b06e |
NDC | 55154-0256 |
Product Type | Human Prescription Drug |
Proprietary Name | Trintellix |
Generic Name | Vortioxetine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2013-10-02 |
Marketing Category | NDA / NDA |
Application Number | NDA204447 |
Labeler Name | Cardinal Health |
Substance Name | VORTIOXETINE HYDROBROMIDE |
Active Ingredient Strength | 10 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2013-10-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204447 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-10-02 |
Ingredient | Strength |
---|---|
VORTIOXETINE HYDROBROMIDE | 10 mg/1 |
SPL SET ID: | cb1e9df4-dd74-4073-9d78-bb55593dd000 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
55154-0256 | Trintellix | vortioxetine |
55154-0257 | Trintellix | vortioxetine |
64764-720 | Trintellix | vortioxetine |
64764-730 | Trintellix | vortioxetine |
64764-750 | Trintellix | vortioxetine |
70518-2642 | Trintellix | Trintellix |
64764-550 | Brintellix | vortioxetine |
64764-560 | Brintellix | vortioxetine |
64764-570 | Brintellix | vortioxetine |
64764-580 | Brintellix | vortioxetine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TRINTELLIX 87109255 5137617 Live/Registered |
H. Lundbeck A/S 2016-07-19 |
TRINTELLIX 86927433 5067548 Live/Registered |
H. Lundbeck A/S 2016-03-03 |
TRINTELLIX 86338883 5023071 Live/Registered |
H. Lundbeck A/S 2014-07-16 |
TRINTELLIX 79388484 not registered Live/Pending |
H. Lundbeck A/S 2023-11-23 |